Underestimated Toxicity: UV Amplifies Low-Dose Cr(VI) Damage to Skin at Molecular and Tissue Levels.

Summary

Using integrated in vitro and in vivo models, the authors show that UV irradiation significantly potentiates the skin toxicity of low-dose hexavalent chromium via ROS-generating redox cycling, leading to DNA/protein cleavage and barrier disruption. Co-exposure increased transepidermal water loss by 50% and induced histologic changes, challenging current threshold-based Cr(VI) safety assumptions under light exposure.

Key Findings

• UV irradiation amplified low-dose Cr(VI) toxicity via ROS-generating redox cycling, causing DNA/protein cleavage and cytotoxicity.
• Acute UV–Cr(VI) co-exposure increased transepidermal water loss by 50% and disrupted stratum corneum/epidermal architecture with inflammatory infiltration.
• Findings challenge threshold-based Cr(VI) safety assumptions under light, suggesting reassessment of environmental/occupational risk and implications for sunscreen formulations.

Clinical Implications

Dermatology and cosmetic safety frameworks should consider UV–Cr(VI) co-exposures; protective measures (e.g., improved photoprotective formulations, exposure controls for workers) may be needed even at low Cr(VI) levels when sunlight exposure is likely.

Limitations

• Specific UV wavelength dependence and chronic co-exposure effects were not fully delineated
• Human clinical exposure-response data were not provided

Future Directions

Define wavelength- and dose–response relationships under chronic co-exposures; translate findings into human-relevant exposure models and evaluate protective interventions (e.g., specific UV filters/antioxidants).